OOIR: Observatory of International Research

Papers

(The H4-Index of Biomarkers is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Association of cardiac biomarkers with long-term cardiovascular events in a community cohort	42
Conjunctival microbiome changes in soft contact lens users and contact lens discomfort patients	31
Nucleosome assembly protein 1-like 1 (NAP1L1) in gastric cancer patients: a potential biomarker with diagnostic and prognostic utility	30
Serum prealbumin level as a biomarker of survival outcomes in patients with gastric cancer: a meta-analysis	25
Neuroprotective effects of magnesium against stress induced by hydrogen peroxide in Wistar rat	21
CYP450 gene polymorphisms and the risk of taxane-induced neurotoxicity in breast cancer patients: a systematic review and meta-analysis	20
Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers	20
Diagnostic significance of the combination of serum CCL20 and Oncostatin M for early-stage endometrial cancer	19
Serum ferritin can serve as a biomarker for the prognosis and increased the prognostic predictive value of ISS/RISS in multiple myeloma patients	17
Investigation of exosomal tetraspanin profile in sepsis patients as a promising diagnostic biomarker	16
Commentary: statistical analysis of 2 × 2 tables in biomarker studies 3) design, interpretation and guidelines	16
Hyponatremia in the emergency department: an overview of diagnostic and therapeutic approach	14
Insight into the role of myokines and myogenic regulatory factors under hypobaric hypoxia induced skeletal muscle loss	14
Commentary: statistical analysis of 2 × 2 tables in biomarker studies 2) study design and statistical tests	14
The prognostic utility of galectin-3 in patients undergoing cardiac surgery: a scoping review	14